AMC Health

Transparency Life Sciences assesses feasibility of decentralized patient data collection

Friday, August 7, 2015

Transparency Life Sciences, a clinical-stage drug development company based on open innovation, has enrolled its first patient in a new ulcerative colitis trial designed to assess the feasibility of replacing most conventional patient site visits with data collected using a combination of decentralized methods, including digital measurements, telemonitoring, remote video visits with clinical trial staff and blood collections by visiting nurses. In addition, the study is the first to allow key clinical endpoint assessments to be made by the subjects’ own gastroenterologists, rather than via designated sub-investigators affiliated with the trial.

[Read More]

AMC Health taps former Beardsworth CEO to head newly formed clinical trials division

Tuesday, July 30, 2013

New York City-based AMC Health, a provider of end-to-end telehealth solutions, has named Michael J. O’Brien president of its Clinical Trials Division, signaling the company’s commitment to expand telemonitoring into broader areas of healthcare. O’Brien will leverage his 30 years of broad-based C-suite experience in the life sciences and information technology industries to meet the surging demand for innovative telemonitoring offerings in clinical drug development.

[Read More]